Dynamic Technology Lab’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Dynamic Technology Lab’s Portfolio ZNTL Stock Details ZNTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-10,546	Closed	-$12K	–	1282
2025 Q2	$12K	Sell	10,546 -9,210	-47%	-$12.1K	﹤0.01%	885
2025 Q1	$31K	Buy	19,756 +2,266	+13%	+$4.89K	﹤0.01%	942
2024 Q4	$53K	Buy	+17,490	New	+$57.3K	0.01%	844
2023 Q2	–	Sell	-10,918	Closed	-$188K	–	1475
2023 Q1	$188K	Buy	+10,918	New	+$221K	0.02%	919

Other funds holding ZNTL

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dynamic Technology Lab's ZNTL Position: Q3 2025 in Review

Dynamic Technology Lab sold out of Zentalis Pharmaceuticals (ZNTL) in Q3 2025, closing a stake of 10,546 shares — an estimated $12K sold.

Dynamic Technology Lab first reported a position in ZNTL in Q1 2023 and held it in 4 quarters. The position peaked at $188K in Q1 2023. 99 funds tracked by Wall St. Rank hold ZNTL as of Q3 2025.

Dynamic Technology Lab reported no remaining Zentalis Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
Dynamic Technology Lab sold 10,546 Zentalis Pharmaceuticals shares in Q3 2025, an estimated $12K.
Dynamic Technology Lab first reported a position in Zentalis Pharmaceuticals in Q1 2023 and held it in 4 quarters.
Dynamic Technology Lab's Zentalis Pharmaceuticals position peaked at $188K in Q1 2023.
99 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q3 2025.

Based on Dynamic Technology Lab's 13F filing for Q3 2025, filed 13 Nov 2025.